Atlas Trials

Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects

Clinical trial NCT02202473 · COMPLETED

Trial details

NCT number
NCT02202473
Sponsor
Southeast University, China
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Primary completion
2014-02-01
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.